Teaser Test

The document is a cost approval request for HyQvia®, a human immunoglobulin therapy, to be submitted to the health insurance under Article 71a-d KVV. The request includes coverage for HyQvia® and associated infusion equipment.

The document details the support offered by various Homecare Services for patients treated by subcutaneous immunoglobulin therapy. It also provides contact information for different homecare providers throughout Switzerland, emphasizing their availability and communication channels. 

The 20th edition of the European Crohn's and Colitis Organisation (ECCO) Congress in Berlin was a complete success!

Following the introduction to HyQvia® and the discussion on the onboarding of new patients in the previous two episodes, this episode focuses on the specific characteristics of HyQvia®.

In this podcast episode, nursing specialist Alina Ladariu discusses her experiences with HyQvia® during the onboarding process of new patients.